Added to YB: 2023-07-06
Pitch date: 2023-07-06
OPTN:US [bullish]
OptiNose, Inc.
-44.35%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists.
Market Cap
$97.2M
Pitch Price
$17.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-11.83
P/E
-3.59
EV/Sales
1.88
Sector
Pharmaceuticals
Category
N/A
Show full summary:
OptiNose, Inc. OPTN:US
A summary for this pitch has not been created yet.
Read full article (0 min)